• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1号染色体1q31.3区域内的常见单倍型决定整个补体因子H蛋白家族的系统浓度。

Common Haplotypes within the Chromosome 1q31.3 Region Determine Systemic Concentrations of the Entire Complement Factor H Protein Family.

作者信息

Veuskens Bert R J, van Rossum Mara, Cattenstart Emi, Brouwer Mieke C, van Mierlo Gerard, Geissler Judy, van Leeuwen Karin, Liu Jin, Anstadt Robert A, Richards Burt T, Hageman Gregory S, Kuijpers Taco W, Toonen Erik J M, Pouw Richard B

机构信息

Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands,

Amsterdam Institute for Immunology and Infectious Diseases, Immunology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands,

出版信息

J Innate Immun. 2025;17(1):244-261. doi: 10.1159/000545342. Epub 2025 Mar 26.

DOI:10.1159/000545342
PMID:40139172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12048132/
Abstract

INTRODUCTION

The alternative pathway of complement activation is consistently active, keeping the complement system primed for immediate response. This constant "tick-over" mechanism is regulated by the factor H (FH) protein family, which encompasses seven highly related proteins: FH, FHL-1, and five FH-related (FHR-1 to -5) proteins. The current model is that the FHRs compete with FH and FHL-1 to fine-tune their activities. Genetic studies of this complex locus have revealed distinct haplotypes associating with a wide array of human diseases, underscoring its significant role in complement regulation. Nevertheless, a comprehensive analysis of systemic concentrations of all FH protein family members, accounting for known genetic variability within the population, is still lacking.

METHODS

Systemic levels of each member of the FH protein family were quantified with the use of recently developed target specific ELISAs. Next, a genetic analysis focused on the chromosome 1q31.3 region was performed using next generation sequencing and multiplex ligase probe-dependent amplification.

RESULTS

We report systemic protein levels of each member of the FH protein family found in vivo and demonstrate common haplotypes within the CFH locus give rise to classifiable protein expression patterns, establishing distinct ratios between FH, FHL-1, and the FHRs.

CONCLUSIONS

The established reference intervals and identified genetic effects provide a benchmark for further research and emphasize the importance of including all family members when studying their role in both health and disease.

摘要

引言

补体激活的替代途径持续活跃,使补体系统随时准备立即做出反应。这种持续的“周转”机制由因子H(FH)蛋白家族调节,该家族包含七种高度相关的蛋白:FH、FHL-1以及五种FH相关(FHR-1至-5)蛋白。目前的模型认为,FHR与FH和FHL-1竞争以微调它们的活性。对这个复杂基因座的遗传学研究揭示了与多种人类疾病相关的不同单倍型,突显了其在补体调节中的重要作用。然而,仍缺乏对所有FH蛋白家族成员全身浓度的综合分析,未考虑人群中已知的基因变异性。

方法

使用最近开发的靶向特异性酶联免疫吸附测定法(ELISA)对FH蛋白家族各成员的全身水平进行定量。接下来,使用下一代测序和多重连接酶探针依赖性扩增对1q31.3染色体区域进行基因分析。

结果

我们报告了在体内发现的FH蛋白家族各成员的全身蛋白水平,并证明CFH基因座内的常见单倍型产生了可分类的蛋白表达模式,确定了FH、FHL-1和FHR之间的不同比例。

结论

既定的参考区间和确定的遗传效应为进一步研究提供了基准,并强调在研究它们在健康和疾病中的作用时纳入所有家族成员的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/7f833261bfa4/jin-2025-0017-0001-545342_F05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/a2b389909a2c/jin-2025-0017-0001-545342_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/e03b062518c8/jin-2025-0017-0001-545342_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/548d2dec4a03/jin-2025-0017-0001-545342_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/5c9e517d368e/jin-2025-0017-0001-545342_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/7f833261bfa4/jin-2025-0017-0001-545342_F05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/a2b389909a2c/jin-2025-0017-0001-545342_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/e03b062518c8/jin-2025-0017-0001-545342_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/548d2dec4a03/jin-2025-0017-0001-545342_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/5c9e517d368e/jin-2025-0017-0001-545342_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f08/12048132/7f833261bfa4/jin-2025-0017-0001-545342_F05.jpg

相似文献

1
Common Haplotypes within the Chromosome 1q31.3 Region Determine Systemic Concentrations of the Entire Complement Factor H Protein Family.1号染色体1q31.3区域内的常见单倍型决定整个补体因子H蛋白家族的系统浓度。
J Innate Immun. 2025;17(1):244-261. doi: 10.1159/000545342. Epub 2025 Mar 26.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy.H因子相关蛋白1和硫酸乙酰肝素结构促成C3肾小球病中的补体失调。
Front Immunol. 2025 May 16;16:1589674. doi: 10.3389/fimmu.2025.1589674. eCollection 2025.
4
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
5
Development and Characterization of Novel ELISAs for the Specific Quantification of the Factor H-Related Proteins 2, 3, 4, and 5.用于特异性定量因子H相关蛋白2、3、4和5的新型酶联免疫吸附测定法的开发与特性分析
J Innate Immun. 2025;17(1):226-243. doi: 10.1159/000545139. Epub 2025 Mar 26.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study.数字病理学与光学显微镜检查在组织病理学切片诊断中的内部及相互间差异:双盲交叉对比研究
Health Technol Assess. 2025 Jul;29(30):1-75. doi: 10.3310/SPLK4325.

引用本文的文献

1
Development and Characterization of Novel ELISAs for the Specific Quantification of the Factor H-Related Proteins 2, 3, 4, and 5.用于特异性定量因子H相关蛋白2、3、4和5的新型酶联免疫吸附测定法的开发与特性分析
J Innate Immun. 2025;17(1):226-243. doi: 10.1159/000545139. Epub 2025 Mar 26.

本文引用的文献

1
Factor H-related 2 levels dictate FHR dimer composition.补体因子H相关蛋白2水平决定了补体因子H二聚体的组成。
Sci Rep. 2025 Mar 28;15(1):10669. doi: 10.1038/s41598-025-94064-4.
2
Development and Characterization of Novel ELISAs for the Specific Quantification of the Factor H-Related Proteins 2, 3, 4, and 5.用于特异性定量因子H相关蛋白2、3、4和5的新型酶联免疫吸附测定法的开发与特性分析
J Innate Immun. 2025;17(1):226-243. doi: 10.1159/000545139. Epub 2025 Mar 26.
3
Factor H-related protein 1 in systemic lupus erythematosus.系统性红斑狼疮中补体因子 H 相关蛋白 1。
Front Immunol. 2024 Jul 29;15:1447991. doi: 10.3389/fimmu.2024.1447991. eCollection 2024.
4
Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots.补体-凝血交叉对话:因子 H 介导的纤维蛋白凝块对补体经典途径激活的调控。
Front Immunol. 2024 Jun 12;15:1368852. doi: 10.3389/fimmu.2024.1368852. eCollection 2024.
5
Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression.补体因子 H 相关蛋白 4 水平不影响年龄相关性黄斑变性的易感性或其进展过程。
Nat Commun. 2024 Jan 10;15(1):443. doi: 10.1038/s41467-023-44605-0.
6
Complement and coagulation crosstalk - Factor H in the spotlight.补体与凝血的相互作用——聚焦于补体因子H
Immunobiology. 2023 Nov;228(6):152707. doi: 10.1016/j.imbio.2023.152707. Epub 2023 Jul 12.
7
Preferential production and secretion of the complement regulator factor H-like protein 1 (FHL-1) by human myeloid cells.人髓样细胞优先产生和分泌补体调控因子 H 样蛋白 1(FHL-1)。
Immunobiology. 2023 May;228(3):152364. doi: 10.1016/j.imbio.2023.152364. Epub 2023 Feb 28.
8
Levels of soluble complement regulators predict severity of COVID-19 symptoms.可溶性补体调节蛋白水平可预测 COVID-19 症状的严重程度。
Front Immunol. 2022 Oct 18;13:1032331. doi: 10.3389/fimmu.2022.1032331. eCollection 2022.
9
Pitfalls in complement analysis: A systematic literature review of assessing complement activation.补体分析的陷阱:评估补体激活的系统文献回顾。
Front Immunol. 2022 Oct 18;13:1007102. doi: 10.3389/fimmu.2022.1007102. eCollection 2022.
10
Evaluating the clinical utility of measuring levels of factor H and the related proteins.评估测量因子 H 及其相关蛋白水平的临床效用。
Mol Immunol. 2022 Nov;151:166-182. doi: 10.1016/j.molimm.2022.08.010. Epub 2022 Sep 23.